Loading...

PE anti-human CD86 Antibody

Pricing & Availability
Clone
IT2.2 (See other available formats)
Regulatory Status
RUO
Workshop
VI CD86.8
Other Names
B7-2, B70
Isotype
Mouse IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IT2.2
Human peripheral blood monocytes stained with IT2.2 PE
  • IT2.2
    Human peripheral blood monocytes stained with IT2.2 PE
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
305405 25 tests $110
Check Availability


Need larger quantities of this item?
Request Bulk Quote
305438 100 µg $292
Check Availability


Need larger quantities of this item?
Request Bulk Quote
305406 100 tests $297
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD86 is an 80 kD immunoglobulin superfamily member also known as B7-2, B70, and Ly-58. CD86 is expressed on activated B and T cells, monocytes/macrophages, dendritic cells, and astrocytes. CD86, along with CD80, is the ligand of CD28 and CD152 (CTLA-4). CD86 is expressed earlier in the immune response than CD80. CD86 has also been shown to be involved in immunoglobulin class-switching and triggering of NK cell-mediated cytotoxicity. CD86 binds to CD28 to transduce costimulatory signals for T cell activation, proliferation, and cytokine production. CD86 can bind to CD152 as well, also known as CTLA-4, to deliver an inhibitory signal to T cells.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Human, Cynomolgus, Rhesus
Reported Reactivity
African Green, Baboon, Capuchin Monkey, Common Marmoset, Cotton-topped Tamarin, Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
µg size: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
test sizes: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
test sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application. For flow cytometric staining using the test sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections6, Western blotting3, and blocking of T cell activation2,4,5. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. Nos. 305449 & 305450).

Application References

(PubMed link indicates BioLegend citation)
  1. Kishimoto T, et al. Eds. 1997. Leucocyte Typing VI. Garland Publishing Inc. London.
  2. Dieu M. 1998. J. Exp. Med. 188:373. (Block)
  3. Esser M, et al. 2001. J. Virol. 75:6173. (WB)
  4. Jeannin P, et al. 1999. J. Immunol. 162:2044. (Block)
  5. Kapsogeorgou EK, et al. 2001. J. Immunol. 166:3107. (Block)
  6. Geissmann F, et al. 2001. Blood 97:1241. (IHC)
Product Citations
  1. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  2. Wildner NH, et al. 2021. J Leukoc Biol. 109:77. PubMed
  3. Hu XX, et al. 2022. Acta Pharmacol Sin. 43:387. PubMed
  4. De León Rodríguez SG, et al. 2022. J Oncol. 2022:9775736. PubMed
  5. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  6. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  7. Sugrue JA, et al. 2022. Cell Rep Med. 3:100804. PubMed
  8. Guo Q, et al. 2023. Front Immunol. 14:1117545. PubMed
  9. Rampal R, Awasthi A, Ahuja V 2016. Sci Rep. 6:30277. PubMed
  10. Macal M, et al. 2016. J Immunol. 196: 1900 - 1909. PubMed
  11. Gu C, et al. 2019. J Immunol. 203:389. PubMed
  12. Li H, et al. 2016. J Immunol. 196: 4064 - 4074. PubMed
  13. Casasola-LaMacchia A, et al. 2021. Sci Rep. 11:1028. PubMed
  14. Schimek V, et al. 2022. Cell Death Dis. 13:113. PubMed
  15. Sugawara E, et al. 2020. Autophagy. 1.323611111. PubMed
  16. Bosco M, et al. 2011. Blood. 117:2625. PubMed
  17. Philippeos C, et al. 2018. J Invest Dermatol. 138:811. PubMed
  18. Kan S, et al. 2020. Int J Oncol. 57:1047. PubMed
  19. Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
  20. Du X, et al. 2018. Cell Res. 28:416. PubMed
  21. Lin JR et al. 2018. eLife. 7 pii: e31657. PubMed
  22. Wang X, et al. 2021. Front Physiol. 12:644903. PubMed
  23. Haruna M, et al. 2020. Biol Pharm Bull. 43:399. PubMed
  24. Jankeel A, et al. 2020. J Virol. :94. PubMed
  25. Hofbauer D, et al. 2021. Immunity. 54(8):1772-1787.e9. PubMed
  26. Oulès B, et al. 2020. Nat Commun. 3.977083333. PubMed
  27. Bryson BD, et al. 2019. Nat Commun. 10:2329. PubMed
  28. Stoeker L, et al. 2011. Clin Vaccine Immunol. 2.023611111. PubMed
  29. Mendoza-Cabrera MI, et al. 2019. Innate Immun. :1753425919864658. PubMed
  30. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  31. Blaszczak AM, et al. 2019. J Diabetes Res. 2019:8124563. PubMed
  32. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  33. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
  34. Barman S, et al. 2016. Int Immunol. 28: 533 - 545. PubMed
  35. Planès R, et al. 2014. J Virol. 88:6672. PubMed
  36. Donini M, et al. 2011. Prostate. 72:566. PubMed
  37. Fiola S, et al. 2010. J Immunol. 185:3620. PubMed
  38. Herati RS, et al. 2022. Nat Immunol. 23:1183. PubMed
  39. Que Y, et al. 2021. Front Immunol. 12:653030. PubMed
  40. Seeger P, et al. 2014. J Immunol. 192:1241. PubMed
  41. Wang X, et al. 2012. J Immunol. 189:3092. PubMed
  42. Finotti G, et al. 2016. J Leukoc Biol. 99: 107 - 119. PubMed
  43. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  44. Koh WH, et al. 2020. STAR Protoc. 1:100203. PubMed
  45. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  46. Welch JL, et al. 2020. FEBS Lett. 594:695. PubMed
  47. Wee Y, et al. 2016. Exp Biol Med. 241: 1217 - 1228. PubMed
RRID
AB_314525 (BioLegend Cat. No. 305405)
AB_314525 (BioLegend Cat. No. 305438)
AB_314525 (BioLegend Cat. No. 305406)

Antigen Details

Structure
Ig superfamily, single-chain transmembrane glycoprotein, 80 kD
Distribution

Monocytes/macrophages, activated B cells and T cells, dendritic cells

Function
T cell costimulation
Ligand/Receptor
CD28, CD152
Cell Type
B cells, Dendritic cells, Macrophages, Monocytes, T cells, Tregs
Biology Area
Cell Biology, Costimulatory Molecules, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Hathcock K, et al. 1996. Adv. Immunol. 62:131.
2. June C, et al. 1994. Immunol. Today 15:321.

Gene ID
942 View all products for this Gene ID
UniProt
View information about CD86 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account